my account  log out
 

Anti-ERBB2 (Trastuzumab-LC-N152)-DBCO-MMAF ADC

Create: 09/27/2017
Expired Date:never
Category: Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:This ADC product is comprised of an anti-ERBB2 monoclonal antibody (Trastuzumab variant,LC-N152) conjugated via a DBCO linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death. https://www.creative-biolabs.com/adc/target-erbb2-37.htm
City:[US] 
Location:
 
Feb 01 2023 VBS++ (with Ca and Mg) Buffer268
Feb 01 2023 GVBE Buffer276
Feb 01 2023 GVB++ (with Ca and Mg) Buffer276
Feb 01 2023 Hemolysin (Rabbit Anti-Sheep Cell Hemolysin)271
Aug 30 2019Anti-HSV-2 gH Antibody461
Aug 30 2019Anti-L. major LPG Antibody543
Aug 30 2019Anti-DENV-1 Antibody451
Aug 30 2019Anti-BPV-1 L1 Antibody465
Aug 30 2019Anti-H3N2 HA Antibody453
Aug 30 2019Anti-EIAV env Antibody474

return back

Copyright © toextrade Inc. All rights reserved. Contact us